3335 Intralesional administration of Coxsackievirus A21 (CVA21) oncolytic virus immunotherapy in patients with advanced melanoma induces durable tumor responses. (September 2015) - Andtbacka, R.H.I.; Curti, B.; Kaufman, H.L.; Daniels, G.A.; Nemunaitis, J.J.; Spitler, L.E.; Hallmeyer, S.; Lutzky, J.; Schultz, S.; Whitman, E.D.; Zhou, K.; Karpathy, R.; et al.